Evidence map›Paper›PMID 38626365›Full record

ArticleJCO oncology practice2024

Prostate Cancer Survivorship and Global Health-Related Quality of Life.

Edward Christopher Dee, Kenrick Ng, Jonathan Shamash, Paul L Nguyen

Abstract readEditorial
In one paragraph

Article in JCO oncology practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Edward Christopher DeeDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0001-6119-0889
Kenrick NgDepartment of Medical Oncology, St Bartholomew's Hospital, Bart's Health NHS Trust, London, United Kingdom.
Jonathan ShamashDepartment of Medical Oncology, St Bartholomew's Hospital, Bart's Health NHS Trust, London, United Kingdom.
Paul L NguyenDepartment of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Biomarker Approaches to Individualizing Systemic Therapy for High Risk Prostate CancerR01CA240582 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FENG, FELIX YI-CHUNG, NGUYEN, PAUL L · 2020 to 2024
$3.4M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA240582
6 · The paper itself

Abstract

Dee, Ng, Shamash, and Nguyen respond to the work of Potosky et al, highlighting the importance of global quality of life in prostate cancer care. Factors such as companionship and spirituality must be considered in providing equitable and whole-person care.

Indexed as

Global HealthProstatic NeoplasmsQuality of LifeCancer SurvivorsHumansMaleSurvivorship

Identifiers

PMID38626365
PMCPMC11972437

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.